LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | LDN-193189 | 0.04 | uM | LJP5 | 72 | hr | 1657 | 5401 | 5505 | 0.9811 | 0.9730 |
Hs 578T | CP724714 | 0.04 | uM | LJP5 | 72 | hr | 929 | 3174 | 3228 | 0.9835 | 0.9768 |
Hs 578T | Crizotinib | 0.04 | uM | LJP5 | 72 | hr | 929 | 3151 | 3228 | 0.9761 | 0.9665 |
Hs 578T | CP466722 | 0.04 | uM | LJP5 | 72 | hr | 929 | 3355 | 3228 | 1.0394 | 1.0554 |
BT-20 | Linifanib | 0.04 | uM | LJP6 | 72 | hr | 1657 | 5888 | 5505 | 1.0694 | 1.0994 |
BT-20 | SB590885 | 0.04 | uM | LJP5 | 72 | hr | 1657 | 5376 | 5505 | 0.9765 | 0.9663 |
BT-20 | Celastrol | 0.04 | uM | LJP6 | 72 | hr | 1657 | 5828 | 5505 | 1.0587 | 1.0839 |
Hs 578T | Alvocidib | 0.04 | uM | LJP6 | 72 | hr | 929 | 2245 | 3228 | 0.6956 | 0.5725 |
BT-20 | Linsitinib | 0.04 | uM | LJP5 | 72 | hr | 1657 | 4776 | 5505 | 0.8676 | 0.8106 |
BT-20 | AT-7519 | 0.04 | uM | LJP6 | 72 | hr | 1657 | 5115 | 5505 | 0.9291 | 0.8986 |
BT-20 | AZD8055 | 0.04 | uM | LJP6 | 72 | hr | 1657 | 2584 | 5505 | 0.4695 | 0.2409 |
Hs 578T | Afatinib | 0.04 | uM | LJP6 | 72 | hr | 929 | 3069 | 3228 | 0.9509 | 0.9311 |
BT-20 | Mitoxantrone | 0.04 | uM | LJP5 | 72 | hr | 1657 | 2816 | 5505 | 0.5115 | 0.3011 |
Hs 578T | AZD-6482 | 0.04 | uM | LJP5 | 72 | hr | 929 | 3064 | 3228 | 0.9492 | 0.9286 |
BT-20 | CGP60474 | 0.04 | uM | LJP5 | 72 | hr | 1657 | 5524 | 5505 | 1.0034 | 1.0049 |
Hs 578T | AT-7519 | 0.04 | uM | LJP6 | 72 | hr | 929 | 3200 | 3228 | 0.9913 | 0.9878 |
BT-20 | Mitoxantrone | 0.04 | uM | LJP6 | 72 | hr | 1657 | 2752 | 5505 | 0.4999 | 0.2845 |
Hs 578T | AZD7762 | 0.04 | uM | LJP6 | 72 | hr | 929 | 1764 | 3228 | 0.5466 | 0.3633 |
Hs 578T | AZD8330 | 0.04 | uM | LJP5 | 72 | hr | 929 | 1531 | 3228 | 0.4745 | 0.2621 |
Hs 578T | AZD8055 | 0.04 | uM | LJP6 | 72 | hr | 929 | 1457 | 3228 | 0.4516 | 0.2299 |
BT-20 | MK2206 | 0.04 | uM | LJP6 | 72 | hr | 1657 | 5368 | 5505 | 0.9751 | 0.9643 |
BT-20 | PIK-93 | 0.04 | uM | LJP5 | 72 | hr | 1657 | 5721 | 5505 | 1.0392 | 1.0560 |
BT-20 | CGP60474 | 0.04 | uM | LJP6 | 72 | hr | 1657 | 1217 | 5505 | 0.2211 | -0.1145 |
MCF 10A | Foretinib | 0.04 | uM | LJP5 | 72 | hr | 513 | 11133 | 10401 | 1.0704 | 1.0741 |
MCF 10A | Erlotinib | 0.04 | uM | LJP5 | 72 | hr | 513 | 9926 | 10401 | 0.9543 | 0.9520 |